Tag: solutions

Los Angeles, California, July 21, 2025 (GLOBE NEWSWIRE) -- XRP has had a great week, hitting an eye-popping $3.66 on Friday, a massive 90% increase from April levels. Now just a stone’s throw away from XRP’s legendary peak of $3.84 during the 2018 bull run, as enthusiasm in the cryptocurrency market soars, PBKMiner has officially launched a groundbreaking innovation: Ripple’s XRP cloud mining contract – no hardware required, daily rewards, and fully remote access for users around the world.
The upward trend continues as global financial institutions increasingly adopt Ripple's liquidity framework. As tokenized assets and stablecoins gradually become mainstream, XRP is more than just a cryptocurrency, it is gradually becoming the backbone of Ripple's plan to unlock more than $100 trillion in global liquidity. As a neutral digital bridge asset, XRP enables fast settlement between different currencies, assets and networks.

MINNEAPOLIS, July 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release second quarter 2025 financial and operating results after market close on Monday, August 4, 2025. The Company will host a conference call to review its results at 4:30pm Eastern Time the same day.

A live webcast of the investor conference call will be available online at the investor relations page of the Company’s website at ir.cvrx.com. To listen to the conference call on your telephone, please dial 1-800-445-7795 for U.S. callers, or 1-785-424-1699 for international callers, approximately ten minutes prior to the start time. Please reference the following conference ID to access the call: CVRXQ225.

About CVRx, Inc.

CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has been certified as compliant with the EU Medical Device Regulation (MDR) and holds CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.

Investor Contact:
Mark Klausner or Mike Vallie
ICR Westwicke
443-213-0501
ir@cvrx.com

Media Contact:
Emily Meyers
CVRx, Inc.
763-416-2853
emeyers@cvrx.com

Saskatoon, SK., July 21, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning developer of drone solutions, software, and robotics, today announced the closing of its previously announced registered direct offering of 4,672,895 units of the Company (the “Units”), at a price of US$5.35 per Unit, for gross proceeds of approximately US$25.0 million, before deducting placement agent discounts and offering expenses (the “Offering”).

BUFFALO, N.Y., July 21, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report second quarter 2025 financial results after market close and host a conference call at 5:00 p.m. ET on Monday, August 11, 2025.

LITTLE ROCK, Ark., July 21, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (NASDAQ: WEST) ("Westrock Coffee" or the “Company") today announced that it will report its second quarter 2025 results on Thursday, August 7, 2025 after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET.